Abstract
Purpose of Review
This review examines the role of executive control processes in the liability for substance misuse and whether substance use, once initiated, leads to subsequent decrements as proposed by neurotoxicity models of substance use disorder (SUD).
Recent Findings
As indicated by a number of recent meta-analyses, executive control processes, which include working memory, cognitive flexibility, and numerous aspects of attentional, behavioral, and emotional control, are impaired in the context of active SUD. Longitudinal studies of behaviorally disinhibited children, individuals with familial risks for SUD, and twins within whom genetic versus environmental influences on behavior can be modeled robustly indicate that relatively poor control is a vulnerability factor for early substance use initiation, binge patterns of use, and subsequent SUD. Evidence of further declines in executive control, once substance use is initiated, is mixed, although a growing number of neuroimaging studies indicate that frontostriatal, frontolimbic, and frontocerebellar systems are altered as a consequence of use.
Summary
Together these patterns suggest strategies for identifying children and adolescents at high risk for SUD, avenues through which substance-related neurotoxicities can be more reliably detected, and the need to structure prevention efforts in a manner that is developmentally appropriate and perhaps personalized to individual vulnerabilities.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, Morozoff C, Shirude S, Unützer J, et al. Trends and patterns of geographic variation in mortality from substance use disorders and intentional injuries among US counties, 1980-2014. JAMA. 2018;319:1013–23.
Jordan CJ, Andersen SL. Sensitive periods of substance abuse: early risk for the transition to dependence. Dev Cogn Neurosci. 2017;25:29–44.
SAMHSA. 2019. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2018 National Survey on Drug Use and Health (HHS Publication No. SMA 18–5068, NSDUH Series H-53). Rockville: Substance Abuse and Mental Health Services Administration; 2018. Retrieved from. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHNationalFindingsReport2018/NSDUHNationalFindingsReport2018.pdf
Newton-Howes G, Cook S, Martin G, Foulds JA, Boden JM. Comparison of age of first drink and age of first intoxication as predictors of substance use and mental health problems in adulthood. Drug Alcohol Depend. 2018. https://doi.org/10.1016/j.drugalcdep.2018.10.012.
Jacobus J, Tapert SF. Neurotoxic effects of alcohol in adolescence. Annu Rev Clin Psychol. 2013;9:703–21.
Stuss DT. Functions of the frontal lobes: relation to executive functions. Psychol Res J Int Neuropsychol Soc. 2011;17(5):759–65.
Friedman NP, Miyake A. Unity and diversity of executive functions: individual differences as a window on cognitive structure. Cortex. 2017;86:186–204.
Nelson TD, Mason A, Nelson JM. Executive control and adolescent health: toward a conceptual framework. Adolesc Res Rev. 2019;4:31–43.
Luciana M. Executive function in adolescence: a commentary on regulatory control and depression in adolescents: findings from neuroimaging and neuropsychological research. J Clin Child Adolesc Psychol. 2016;45(1):84–9.
Zainal NH, Newman MG. Within-person increase in pathological worry predicts future depletion of unique executive functioning domains. Psychol Med. 2020:1–11.
Verbruggen, F. Executive control of actions across time and space Curr. Dir Psychol Sci 2016; 25: 399–404.
McTeague LM, Huemer J, Carreon DM, Jiang Y, Eickhoff SB, Etkin A. Identification of common neural circuit disruptions in cognitive control across psychiatric disorders. Am J Psychiatry. 2017;174:676–85.
Schmeichel BJ. Attention control, memory updating and emotion regulation temporarily reduce the capacity for executive control. J Exp Psychol Gen. 2017;136(2):241–55.
Fiske A, Holmboe K. Neural substrates of early executive function development. Dev Rev. 2019;52:42–62.
Best JR, Miller PH. A developmental perspective on executive function. Child Dev. 2010;81(6):1641–60.
Luciana M, Conklin HM, Hooper CJ, Yarger RS. The development of nonverbal working memory and executive control processes in adolescents. Child Dev. 2005;76(3):697–712.
Luna B, Padmanabhan A, O'Hearn K. What has fMRI told us about the development of cognitive control through adolescence? Brain Cogn. 2010;72:101–13.
Breiner K, Li A, Cohen AO, Steinberg L, Bonnie RJ, Scott ES, et al. Combined effects of peer presence, social cues, and rewards on cognitive control in adolescents. Dev Psychobiol. 2018;60:292–302.
Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760–73.
Selemon LD. A role for synaptic plasticity in the adolescent development of executive function. Transl Psychiatry. 2013;3(3):e238.
Broyd SJ, van Hell HH, Beale C, Yücel M, Solowij N. Acute and chronic effects of cannabinoids on human cognition—a systematic review. Biol Psychiatry. 2016;79:557–67.
Chen S, Yang P, Chen T, Su H, Jiang H, Zhao M. Risky decision-making in individuals with substance use disorder: a meta-analysis and meta-regression review. Psychopharmacology. 2020;237:1893–908. https://doi.org/10.1007/s00213-020-05506-y.
Figueiredo PR, Tolomeo S, Steele JD, Baldacchino A. Neurocognitive consequences of chronic cannabis use: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2020;108:358–69.
Gorey C, Kuhns L, Smaragdi E, Kroon E, Cousijn J. Age-related differences in the impact of cannabis use on the brain and cognition: a systematic review. Eur Arch Psychiatry Clin Neurosci. 2019;10:15.
Lovell ME, Akhurst J, Padgett C, Garry MI, Matthews A. Cognitive outcomes associated with long-term, regular, recreational cannabis use in adults: a meta-analysis. Exp Clin Psychopharmacol. 2019. https://doi.org/10.1037/pha0000326.
Mahoney JJ, Bryant KR, Haut MW. Substance use disorders: cognitive sequelae, behavioral manifestations, neuroimaging correlates and novel interventions. In Armstrong, CL, Morrow, LA, Editors: Handbook of Medical Neuropsychology: Applications of Cognitive Neuroscience. Springer Nature. 2019; 697–726.
Ramy T, Regier PS. Cognitive impairment in substance use disorders. CNS Spectrums. 2019;24:102–13.
Roberts CA, Jones A, Montgomery C. Meta-analysis of executive functioning in ecstasy/polydrug users. Psychol Med. 2016;46(8):1581–96.
Scott JC, Slomiak ST, Jones JD, Rosen AF, Moore RM, Gur RC. Association of cannabis with cognitive functioning in adolescents and young adults: a systematic review and meta-analysis. JAMA Psychiatry. 2018;75:585–95.
Stephan RA, Alhassoon OM, Allen KE, Wollman SC, Hall M, Thomas WJ, …, Grant, I Meta-analyses of clinical neuropsychological tests of executive dysfunction and impulsivity in alcohol use disorder. Am J Drug Alcohol Abuse 2016; 12: 1–20.
Sullivan EV, Pfefferbaum A. Brain-behavior relations and effects of aging and common comorbidities in alcohol use disorder: a review. Neuropsychology. 2019;33(6):760–80.
Tervo-Clemmens B, Quach A, Calabro FJ, Foran W, Luna B. Meta-analysis and review of functional neuroimaging differences underlying adolescent vulnerability to substance use. Neuro Image. 2020;209:1–12.
Bloomfield MAP, Hindocha C, Green SF, Wall MB, Lees R, Petrilli K, et al. The neuropsychopharmacology of cannabis: a review of human imaging studies. Pharmacol Ther. 2019;195:132–61.
Chye Y, Christensen E, Yucel M. Cannabis use in adolescence: a review of neuroimaging findings. J Dual Diagn. 2020. https://doi.org/10.1080/15504263.15502019.11636171.
Zilverstand A, Parvaz MA, Goldstein RZ. Neuroimaging cognitive reappraisal in clinical populations to define neural targets for enhancing emotion regulation. A systematic review. Neuroimage. 2017;151:105–16.
Biernacki K, Mclennan SN, Terrett G, Labuschagne I, Rendell PG. Decision-making ability in current and past users of opiates: a meta-analysis. Neurosci Biobehav Rev. 2016;71:342–51.
Verdejo-Garcia, A. Executive dysfunction in addiction. In E Goldberg (Ed): Executive Functions in Health and Disease. Elsevier. 2017; https://doi.org/10.1016/B978-0-12-803676-1.00016-7: 395-403.72.
Anderson BA. What is abnormal about addiction-related attentional biases? Drug Alcohol Depend. 2016;167:8–14.
Haeny AM, Gueorguieva R, Morean ME, Krishnan Sarin S, DeMartini KS, Pearlson GD, ..., O'Malley SS. The association of impulsivity and family history of alcohol use disorder on alcohol use and consequences. Alcohol Clin Exp Res 2020; 44 (1): 159–167.
Duijkers JCLM, Vissers CTWM, Egger JIM. Unraveling executive functioning in dual diagnosis. Front Psychol. 2016;7:979.
Wills TA, Simons JS, Sussman S, Knight R. Emotional self-control and dysregulation: a dual-process analysis of pathways to externalizing/internalizing symptomatology and positive well-being in younger adolescents. Drug Alcohol Depend. 2016;163(Suppl 1):S37–45.
Windle M Behavioral undercontrol: a multifaceted concept and its relationship to alcohol and substance use disorders. In Zucker, RA, Brown SA, Editors: Oxford Handbook of Adolescent Substance Use Disorders. Oxford University Press; 2019.
Venables NC, Foell J, Yancey JR, Kane MJ, Engle RW, Patrick CJ. Quantifying inhibitory control as externalizing proneness: a cross-domain model. Clin Psychol Sci. 2018;6(4):561–80.
Huang-Pollock C, Shapiro Z, Galloway-Long H, Weigard A. Is poor working memory a transdiagnostic risk factor for psychopathology? J Abnorm Child Psychol. 2017;45:1477–90.
Tervo-Clemmens B, Quach A, Luna B, Foran W, Chung T, DeBellis MD, et al. Neural correlates of rewarded response inhibition in youth at risk for problematic alcohol use. Front Behav Neurosci. 2017;11:205.
Verdejo-García A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev. 2008;32:777–810.
McGue M, Iacono WG, Legrand LN, Elkins I. The origins and consequences of age at first drink. I. Associations with substance-use disorders, disinhibitory behavior and psychopathology, and P3 amplitude. Alcohol Clin Exp Res. 2001;25(8):1156–65.
Dick DM, Aliev F, Latendresse SJ, Hickman M, Heron J, Macleod J, et al. Adolescent alcohol use is predicted by childhood temperament factors before age 5, with mediation through personality and peers. Alcohol Clin Exp Res. 2013;37(12):2108–17.
Meier MH, Hall W, Caspi A, Belsky DW, Cerda M, Harrington HL, et al. Which adolescents develop persistent substance dependence in adulthood? Using population-representative longitudinal data to inform universal risk assessment. Psychol Med. 2016;46(4):877–89.
Groenman A, Oosterlaan J, Greven C, Jelle Vuijk P, Rommelse N, Franke B, …, Buitelaar J. Neurocognitive predictors of substance use disorders and nicotine dependence in ADHD probands, their unaffected siblings, and controls: a 4-year prospective follow-up. J Child Psychol Psychiatry 2015; 56(5): 521–529.
• Zellers SM, Corley R, Thibodeau E, Kirkpatrick R, Elkins I, Iacono WG, et al. Adolescent externalizing psychopathology and its prospective relationship to marijuana use development from age 14 to 30: replication across independent longitudinal twin samples. Behav Genet. 2020;50:139–51 This important study utilized two independent twin samples and state-of-the-art statistical modeling to demonstrate that externalizing psychopathology in adolescence is genetically correlated with changes in late adolescent marijuana use and with maintenance of use in young adulthood.
Farmer RF, Gau JM, Seeley JR, Kosty DB, Sher KJ, Lewinsohn PM. Internalizing and externalizing disorders as predictors of alcohol use disorder onset during three developmental periods. Drug Alcohol Depend. 2016;164:38–46.
Pentz MA, Shin H, Riggs N, Unger J, Collison K, Chou C. Parent, peer, and executive function relationships to early adolescent e-cigarette use: a substance use pathway? Addict Behav. 2015;42:73–8.
• Wilson S, Malone SM, Venables NC, McGue M, Iacono WG. Multimodal indicators of risk for and consequences of substance use disorders: executive functions and trait dysconstraint assessed from preadolescence into early adulthood. Int J Psychophysiol. 2019. https://doi.org/10.1016/j.ijpsycho.2019.12.007This study incorporated a multimodal assessment of disinhibition and followed children from preadolescence into young adulthood, finding that low levels of constraint and working memory were premorbid risk factors for later substance misuse. An important finding was that those who engaged in later substance use showed deviant trajectories in the development of laboratory-measured inhibitory control.
Peeters M, Janssen T, Monshouwer K, Boendermaker W, Pronk T. Weaknesses in executive functioning predict the initiating of adolescents’ alcohol use. Dev Cogn Neurosci. 2015;16:139–46.
Sullivan EV, Brumback T, Tapert SF, Fama R, Prouty D, Brown SA, et al. Cognitive, emotion control, and motor performance of adolescents in the NCANDA study: contributions from alcohol consumption, age, sex, ethnicity, and family history of addiction. Neuropsychology. 2016;30:449–73.
Clark DB, Chung T, Martin CS, Hasler BP, Fitzgerald DH, Luna B, et al. Adolescent executive dysfunction in daily life: relationships to risks, brain structure and substance use. Front Behav Neurosci. 2017;11:223.
Jones CB, Meier MH, Corbin WE, Chassin L. Adolescent executive cognitive functioning and trait impulsivity as predictors of young-adult risky drinking and alcohol-related problems. Psychol Addict Behav. 2020; Advance online publication. https://doi.org/10.1037/adb0000636.
Peeters M, Monshouwer K, Schoot RA, Janssen T, Vollebergh WAM, Wiers RW. Automatic processes and the drinking behavior in early adolescence: a prospective study. Alcohol Clin Exp Res. 2013;37(10):1737–44.
Kim-Spoon J, Deater-Deckard K, Holmes CJ, Lee JI, Chiu PH, King-Casas B. Behavioral and neural inhibitory control moderates the effects of reward sensitivity on adolescent substance use. Neuropsychologia. 2016;91:318–26.
Strickhouser JE, Terracciano A, Sutin AR. Parent-reported childhood temperament and adolescent self-reported substance use initiation. Addict Behav. 2020;110:106503.
Quach A, Tervo-Clemmens B, Foran W, Calabro FJ, Chung T, Clark DB, et al. Adolescent development of inhibitory control and substance use vulnerability: a longitudinal neuroimaging study. Dev Cogn Neurosci. 2020;42:100771.
Heitzeg MM, Cope LM, Martz ME, Hardee JE. Neuroimaging risk markers for substance abuse: recent findings on inhibitory control and reward system functioning. Curr Addict Rep. 2015;2:91–103.
Courtney KE, Ghahremani DG, Ray LA. Frontostriatal functional connectivity during response inhibition in alcohol dependence. Addict Biol. 2013;18(3):593–604.
Nixon SJ. Executive functioning among young people in relation to alcohol use. Curr Opinions Psychiatry. 2013;26(4):305–9.
Dick DM, Agrawal A. The genetics of alcohol and other drug dependence. Alcohol Res Health. 2008;31(2):111–8.
Acheson A, Lake SL, Bray BC, Liang Y, Mathias CW, Ryan SR, et al. Early adolescent trajectories of impulsiveness and sensation seeking in children of fathers with histories of alcohol and other substance use disorders. Alcoholism. 2016;40:2622–30.
Acheson A. Behavioral processes and risk for problem substance use in adolescents. Pharmacol Biochem Behav. 2020;198:173021. https://doi.org/10.1016/j.pbb.2020.173021.
De Vito EE, Meda SA, Jiantonio R, Potenza MN, Krystal JH, Pearlson GD. Neural correlates of impulsivity in healthy males and females with family histories of alcoholism. Neuropsychopharmacology. 2013;38:1854–63.
Jones SA, Nagel BJ. Altered frontostriatal white matter microstructure is associated with familial alcoholism and future binge drinking in adolescence. Neuropsychopharmacology. 2020;44:1076–83.
Cservenka A. Neurobiological phenotypes associated with a family history of alcoholism. Drug Alcohol Depend. 2016;158:8–21.
Euser AS, Arends LR, Evans BE, Greaves-Lord K, Huizink AC, Franken IHA. The P300 event-related brain potential as a neurobiological endophenotype for substance use disorders: a meta-analytic investigation. Neurosci Biobehav Rev. 2012;36:572–603.
Squeglia LM, Cservenka A. Adolescence and drug use vulnerability: findings from neuroimaging. Curr Opin Behav Sci. 2017;13:164–70.
• Lees B, Aguinaldo L, Squeglia LM, Infante MA, Wade NE, Hernandez Mejia M, et al. Parental family history of alcohol use disorder and neural correlates of response inhibition in children from the Adolescent Brain Cognitive Development (ABCD) Study. Alcohol Clin Exp Res. 2020. https://doi.org/10.1111/acer.14343This influential study utilized data from the ABCD study Consortium to demonstrate that children with positive family histories of alcohol misuse show deviant patterns of neural activation while completing an fMRI Stop Signal task measure of response inhibition.
Kendler KS, Sundquist K, Ohlsson H, Palmer K, Maes H, Winkleby MA, et al. Genetic and familial environmental influences on the risk for drug abuse: a national Swedish adoption study. Arch Gen Psychiatry. 2012;69(7):690–7.
Hicks BM, Krueger RF, Iacono WG, McGue M, Patrick CJ. Family transmission and heritability of externalizing disorders: a twin-family study. Arch Gen Psychiatry. 2004;61:922–8.
Friedman NP, Miyake A, Young SE, DeFries JC, Corley RP, Hewitt JK. Individual differences in executive functions are almost entirely genetic in origin. J Exp Psychol Gen. 2008;137:201–25.
Anokhin AP, Golosheykin S, Grant JD, Heath AC. Heritability of delay discounting in adolescence: a longitudinal twin study. Behav Genet. 2012;41(2):175–83.
Gustavson DE, Stallings MC, Corley RP, Miyake A, Hewitt JK, Friedman NP. Executive functions and substance use: relations in late adolescence and early adulthood. J Abnorm Psychol. 2017;126(2):257–70.
Moszczynska A, Callan SP. Molecular, behavioral, and physiological consequences of methamphetamine neurotoxicity: implications for treatment. J Pharmacol Exp Ther. 2017;362:474–88.
Sarkar S, Schmued L. Neurotoxicity of ecstasy (MDMA): an overview. Curr Pharm Biotechnol. 2010;11:460–9.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.
George O, Koob GF. Individual differences in prefrontal cortex function and the transition from drug use to drug dependence. Neurosci Biobehav Rev. 2010;35:232–47.
George O, Mandyam CD, Wee S, Koob GF. Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments. Neuropsychopharmacology. 2008;33:2474–82.
Ben-Shahar O, Obara I, Ary AW, Ma N, Mangiardi MA, Medina RL, et al. Extended daily access to cocaine results in distinct alterations in Homer 1b/c and NMDA receptor subunit expression within the medial prefrontal cortex. Synapse. 2009;63:598–609.
Frazer KM, Richards Q, Keith DR. The long-term effects of cocaine use on cognitive functioning: a systematic critical review. Behav Brain Res. 2018;348:241–62.
Paige KJ, Colder CR. Long-term effects of early adolescent marijuana use on attentional and inhibitory control. J Stud Alcohol Drugs. 2020;81(2):164–72.
Gonzalez R, Pacheco-Colón I, Duperrouzel JC, Hawes SW. Does cannabis use cause declines in neuropsychological functioning? A review of longitudinal studies. J Int Neuropsychol Soc JINS. 2017;23:893–902.
Becker M, Collins PF, Schultz A, Urosevic S, Schmaling B, Luciana M. Longitudinal change in cognition in young adult cannabis users. J Clin Exp Neuropsychol. 2017. https://doi.org/10.1080/13803395.2017.1385729.
Jacobus J, Squeglia LM, Infante MA, Castro N, Brumback T, Meruelo AD, et al. Neuropsychological performance in adolescent marijuana users with co-occurring alcohol use: a three-year longitudinal study. Neuropsychology. 2015;29(6):829–43.
•• Ross JM, Ellingson JM, Rhee SH, Hewitt JK, Corley RP, Lessem JM, et al. Investigating the causal effect of cannabis use on cognitive function with a quasi-experimental co-twin design. Drug Alcohol Depend. 2020;206:107712. https://doi.org/10.1016/j.drugalcdep.2019.10771This important longitudinal twin study used a quasi-experimental co-twin design to examine causal effects of cannabis use on cognitive functions, finding little-to-no support for cannabis-induced impairments in executive functions.
•• Khurana A, Romer D, Betancourt LM, Hurt H. Working memory ability and early drug use progression as predictors of adolescent substance use disorders. Addiction. 2017;112(7):1220–8 This well-designed longitudinal study assessed adolescents across five waves, finding strong evidence that decrements in working memory abilities, measured using well-validated tasks, represent premorbid liabilities for later SUD; working memory did not further decline as a function of the development of an SUD.
Boelema SR, Harakeh Z, van Zandvoort MJE, Reijneveld SA, Verhulst FC, Ormel J, et al. Adolescent heavy drinking does not affect maturation of basic executive functioning: longitudinal findings from the TRAILS study. PLoS One. 2015;10(10):e0139186.
Cutuli D, Ladrón de Guevara-Miranda D, Castilla-Ortega E, Santín LJ, Sampedro-Piquero P. Highlighting the role of cognitive and brain reserve in the substance use disorder field. Curr Neuropharmacol. 2019;17:1056–70.
Luciana M, Collins PF, Muetzel RL, Lim KO. Effects of alcohol use initiation on brain structure in typically developing adolescents. Am J Drug Alcohol Abuse. 2013;39(6):345–55.
Pfefferbaum A, Kwon D, Brumback T, Thompson WK, Cummins K, Tapert SF, et al. Altered brain development trajectories in adolescents after initiating drinking. Am J Psychiatr. 2018;175(4):370–80.
Sullivan EV, Brumback T, Tapert SF, Brown SA, Baker FC, Colrain IM, et al. Disturbed cerebellar growth trajectories in adolescents who initiate alcohol drinking. Biol Psychiatry. 2019;87(7):632–44.
• Robert GH, Luo Q, Yu T, Chu C, Ing A, Jia T, et al. Association of gray matter and personality development with increased drunkenness frequency during adolescence. JAMA Psychiatry. 2019;18:18 This longitudinal neuroimaging study followed early adolescents enrolled in the IMAGEN Consortium. While participants who subsequently reported substance misuse could be characterized by several deviations in cortical structure, causal Bayesian estimation analyses suggested that many of the observed patterns were attributable to premorbid differences, raising questions about neurotoxicity models of substance misuse.
Duperrouzel JC, Granja K, Pacheco-Colón I, Gonzalez R. Adverse effects of cannabis use on neurocognitive functioning: a systematic review of meta-analytic studies. Journal of Dual Diagnosis. 2019;16:43–57. https://doi.org/10.1080/15504263.2019.1626030.
Brown SA, Brumback T, Tomlinson K, Cummins K, Thompson WK, Nagel BJ, et al. The National Consortium on Alcohol and NeuroDevelopment in Adolescence (NCANDA): a multi-site study of adolescent development and substance use. J Stud Alcohol Drugs. 2015;76:895–908.
Feldstein Ewing SW, Bjork JM, Luciana M. Implications of the ABCD study for developmental neuroscience. Dev Cogn Neurosci. 2018;32:161–4.
Kooijman MN, Kruithof CJ, van Duijn CM, Duijts L, Franco OH, van IJzendoorn MH, et al. The Generation R Study: design and cohort update 2017. Eur J Epidemiol. 2016;31(12):1243–64.
Nixon SJ, Lewis B. Cognitive training as a component of treatment of alcohol use disorder: a review. Neuropsychology. 2019;33(6):822–41.
Romer D, Reyna VF, Satterthwaite TD. Beyond stereotypes of adolescent risk taking: placing the adolescent brain in developmental context. Dev Cogn Neurosci. 2017;27:19–34.
Acknowledgments
This work was supported by the National Institutes of Health grants U01DA041120 and R56MH122473. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.
Funding
The author’s work on this review paper was supported by the National Institutes of Health grants U01DA041120 and R56MH122473.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The author has no conflicts of interest to disclose.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Adolescent/Young Adult Addiction
Rights and permissions
About this article
Cite this article
Luciana, M. Risks Versus Consequences of Adolescent and Young Adult Substance Use: a Focus on Executive Control. Curr Addict Rep 7, 453–463 (2020). https://doi.org/10.1007/s40429-020-00341-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40429-020-00341-9